Sarcoma News

Breakthrough Study Finds Menin Inhibitors Block Ewing Sarcoma Metastasis

This research article, titled “Menin inhibition impairs metastatic colonization of Ewing sarcoma” (published in JCI Insight by Katherine A. Braun et al.), investigates how targeting a specific protein called Menin can help stop Ewing sarcoma from spreading to other parts of the body. While Menin inhibitors have already shown promise in treating certain blood cancers like leukemia, this study explores whether blocking Menin can also be used as a targeted therapy to disrupt the growth and metastasis of Ewing sarcoma tumors.

Cancer becomes most dangerous when tumor cells spread (colonize) to secondary organs like the lungs. The researchers discovered that blocking Menin or knocking out its function doesn’t necessarily prevent Ewing sarcoma cells from growing in a petri dish, but it drastically weakens their ability to travel, settle, and grow into new tumors inside a living body. By using a drug called a Menin inhibitor (such as VTP50469 / revumenib), scientists were able to disrupt the interaction between Menin and another key cancer-promoting protein called MYC, effectively preventing the cancer cells from forming distant metastases. Ultimately, these findings suggest that Menin inhibitors could become a valuable new treatment option for patients facing high-risk or metastatic Ewing sarcoma.

Read the full article

Matt Strong All Day Long Store

Leave a Reply

Your email address will not be published. Required fields are marked *